课题基金 / 基金详情

Gene therapy for gastrointestinal tumors using antigen presenting cells activated with gene transfer

Gene therapy for gastrointestinal tumors using antigen presenting cells activated with gene transfer
使用通过基因转移激活的抗原呈递细胞进行胃肠道肿瘤的基因治疗
批准号:
13671367
负责人:
TAGAWA Masatoshi
金额:
$2.62万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

TAGAWA Masatoshi的其他基金

相似基金

相关文献

中文摘要
翻译
我们研究了是否可以通过在肿瘤上表达CD 40配体(CD 40 L)基因来激活专职抗原呈递细胞(树突状细胞),并随后诱导抗肿瘤免疫。我们逆转录病毒转导肿瘤与CD 40 L基因,并建立CD 40 L表达的肿瘤,其MHC I类表达保持相同的亲本肿瘤。将转导的细胞接种到同基因小鼠中,发现与亲本肿瘤相比,表达CD 40 L的肿瘤的生长显著延迟。一些小鼠完全排斥表达CD 40 L的肿瘤,小鼠产生了抗原特异性保护性免疫。当裸鼠接种表达CD 40 L的肿瘤时,其生长与亲本肿瘤没有差异。在体外培养的CD 40 L表达的肿瘤和骨髓来源的树突状细胞显示,树突状细胞和CD 40 L表达的肿瘤之间的集群形成,而不是母瘤。与表达CD 40 L的肿瘤细胞共培养后,树突状细胞上的MHC II类分子和活化标志物CD 86的表达上调,但与亲代肿瘤细胞共培养后,树突状细胞上的MHC II类分子和活化标志物CD 86的表达上调。活化的树突状细胞分泌IL-12、IL-18、IL-23和Mig。这些数据共同表明,肿瘤上的CD 40 L可以通过CD 40/CD 40 L相互作用激活树突状细胞,并诱导细胞因子和趋化因子的表达,这在T细胞介导的抗肿瘤效应的产生中起着至关重要的作用。
英文摘要
We examined whether professional antigen presenting cells (dendritic cells) could be activated by the expression of CD40 ligand (CD40L) gene on tumors and antitumor immunity was subsequently induced. We retrovirally transduced tumors with the CD40L gene and established CD40L-expressed tumors whose MHC class I expression remained the same as that of parent tumors. Inoculation of the transduced cells into syngeneic mice revealed that growth of CD40L-expressed tumors was significantly retarded compared with that of parent tumors. Some of the mice completely rejected the CD40L-expressed tumors and the mice developed antigen-specific protective immunity. When nude mice were inoculated with the CD40L-expressed tumors, the growth was not different from that of parent tumors. In vitro culture of the CD40L-expressed tumors and bone marrow-derived dendritic cells showed that the cluster formation between dendritic cells and the CD40L-expressed but not parent tumors. The expression of MHC class II and activation marker CD86 on dendritic cells was upregulated after the coculture with CD40L-expressed but not parent tumors. The activated dendritic cells secreted IL-12, IL-18, IL-23 and Mig. These data collectively suggest that CD40L on tumors can activate dendritic cells through CD40/CD40L interaction and induce the expression of cytokines and chemokines, which play a crucial role in the generation of T cell-mediated antitumor effects.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
Miyauchi M, Tagawa M, et al.: "Expression of herpers simplex virus-thymidine kinase gene controlled by a promoter region of the midkine rene confers selsctive cytotoxicity to ganciclovir in humancarcinoma cells"Int. J. Cancer. 91. 723-727 (2001)
Miyauchi M、Takawa M 等人:“受中期因子 rene 启动子区域控制的单纯疱疹病毒胸苷激酶基因的表达赋予更昔洛韦在人癌细胞中的选择性细胞毒性”Int。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yoshida Y, Tagawa M, et al.: "A promoter region of midkine gene can activate transcription of an exogenous suicide gene in human pancreatic cancer"Anticancer Res.. 22. 117-120 (2002)
Yoshida Y、Takawa M 等人:“中期因子基因的启动子区域可以激活人胰腺癌中外源性自杀基因的转录”Anticancer Res. 22. 117-120 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tomizawa M, tagawa M, et al.: "Decreased expression of the CCAAT/enhancer binding protein α gene involved in hepatocyte proliferation in human hepatocellular carcinoma"Int.J.Mol.Med.. 9. 597-600 (2002)
Tomizawa M、takawa M等人:“人肝细胞癌中参与肝细胞增殖的CCAAT/增强子结合蛋白α基因的表达降低”Int.J.Mol.Med..9.597-600(2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 34 条
    Molecular therapy for esophageal cancer targeting the p53 and the Hippo pathways
    • 批准号:
      17K10617
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2017
    • 负责人:
      TAGAWA Masatoshi
    • 依托单位:
    Combinatory use of replication-competent adenoviruses and chemotherapeutic agents produces anti-tumor effects on human esophageal carcinoma cells
    • 批准号:
      23591951
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2011
    • 负责人:
      TAGAWA Masatoshi
    • 依托单位:
    Mesenchymal stem cells infected with modified adenoviruses as carrier cells that target human gastrointestinal tumors
    • 批准号:
      20591585
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      TAGAWA Masatoshi
    • 依托单位:
    Oncolytic adenovirus modified to increase its infectivity for gastrointestinal cancer
    • 批准号:
      16591381
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2004
    • 负责人:
      TAGAWA Masatoshi
    • 依托单位:
    国内基金
    海外基金
    CD40 ligand 转基因B淋巴瘤细胞来源exosome的抗肿瘤作用
    • 批准号:
      81071948
    • 项目类别:
      面上项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2010
    • 负责人:
      刘爱春
    • 依托单位: